Moreover, expression levels of Bax, Bax/Bcl2 ratio and the counts of CD68+, CD11b+ and TUNEL-positive cells within the affected brain area of the NPC-CM-treated animals were significantly higher than for the GPC-CM-treated group. This evidence concerns the gene BAX and nasopharyngeal carcinoma.